Quest Diagnostics (DGX) New Study Exposes Alarming Data on STI
Quest Diagnostics (DGX) joint study with the University of Alabama finds pregnant women undertested for STIs, raising serious concerns on…
206,698$
-0,08%
Echtzeit-Aktienkurs Quest Diagnostics Inc.
Bid:
Ask:
Nachrichten zur Quest Diagnostics Inc. Aktie
Quest Diagnostics stock hits 52-week high at $151.94 By Investing.com
Quest Diagnostics stock hits 52-week high at $151.94…
Quest Diagnostics (DGX) Gains From Innovation, Customer Wins
A key driver in Brain Health growth is Quest Diagnostics (DGX) Alzheimers disease portfolio, featuring the AD-Detect blood testing services…
Should Quest Diagnostics (DGX) be in Your Portfolio Now?
Quest Diagnostics (DGX) robust base business performance instills optimism for long-term growth.…
Quest Diagnostics (DGX) Haystack Oncology Forges New MRD Deal
Quest Diagnostics (DGX) subsidiary, Haystack Oncology, partners on the use of its MRD technology.…
Quest Diagnostics (DGX) Q2 Earnings and Revenues Top Estimates
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 1.73% and 0.50%, respectively, for the quarter ended June 2024. Do…
Quest Diagnostics: On A Quest For Growth
…
What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release?
Quest Diagnostics (DGX) is likely to have maintained its robust base business performance in the second quarter of 2024. However,…
Quest Diagnostics to acquire certain assets from OhioHealth
…
Global Precision Diagnostics Market Size To Worth USD 254.48 Billion By 2033 | CAGR Of 13%
The Global Precision Diagnostics Market Size was Valued at USD 74.98 Billion in 2023 and the Worldwide Precision Diagnostics Market…
Quest Diagnostics (DGX) to Expand in Canada With LifeLabs Buyout
By integrating LifeLabs into its operations, Quest Diagnostics (DGX) aims to enhance the accessibility and quality of diagnostic services for…
Global PCOS Diagnostic Market Size To Exceed USD 6.1 Billion By 2033 | CAGR Of 5.18%
The Global PCOS Diagnostic Market Size was Valued at USD 3.68 Billion in 2023 and the Worldwide PCOS Diagnostic Market…
Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now?
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues…
PTA-News: Small- & MicroCap Investment: KI als Wachstumsmotor: CrowdStrike, Adcore, Quest Diagnostics
DJ PTA-News: Small- & MicroCap Investment: KI als Wachstumsmotor: CrowdStrike, Adcore, Quest Diagnostics Unternehmensmitteilung für den Kapitalmarkt Frankfurt (pta/23.06.2024/10:00) -…
Quest Diagnostics (DGX) Gains From New M&As Amid Competition
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share…
Quest Diagnostics (DGX) New Buyout Ramps Up Cancer Diagnosis
Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer…
Analyst Report: Quest Diagnostics, Inc.
…
Quest Diagnostics said to be nearing deal for Canadas Lifelabs
…
Kaum Impulse für die Quest Diagnostics-Aktie (127,3380 €)
Wenig Kursbewegung aktuell bei der Aktie von Quest Diagnostics . Der jüngste Kurs betrug 136,84 US-Dollar. Die Wertschätzung der Börsenteilnehmer…
Quest Diagnostics: Lets Keep Waiting
…
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics (DGX) pathology laboratories nationwide are set to get a boost with PathAIs AISight digital pathology image management system.…
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics (DGX) latest transaction combines its oncology expertise and scale with PathAIs AI and digital pathology innovations.…
Quest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down
Quest Diagnostics (DGX) continues its strong momentum of base business revenue growth in the first quarter of 2024.…
Minimale Kursveränderung bei Quest Diagnostics-Aktie (120,7245 €)
CODE Das Wertpapier notiert aktuell bei 128,30 US-Dollar. Kaum auffällig ist derzeit an der Börse der Kurs von Quest Diagnostics.…
Quest Diagnostics (DGX) to Post Q1 Earnings: Whats in Store?
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics (DGX) base business performance in the first quarter…
Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs
Quest Diagnostics (DGX) collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal…
Analyst Report: Quest Diagnostics, Inc.
…
Quest Diagnostics (DGX) Hurt by Lower Testing Sales, Competition
Quest Diagnostics (DGX) faces intense competition, primarily from LabCorp as well as other commercial laboratories and hospitals.…